Rock Creek Group’s Pfizer PFE Stock Holding History

Rock Creek Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,776	Closed	-$92.1K	–	150
2023 Q3	$92.1K	Sell	2,776 -1,454	-34%	-$51.4K	0.01%	115
2023 Q2	$155K	Buy	4,230 +226	+6%	+$8.8K	0.02%	104
2023 Q1	$163K	Sell	4,004 -1,342	-25%	-$58K	0.02%	105
2022 Q4	$274K	Buy	5,346 +3,194	+148%	+$153K	0.03%	79
2022 Q3	$94K	Sell	2,152 -1,015	-32%	-$49.3K	0.01%	117
2022 Q2	$166K	Sell	3,167 -772	-20%	-$39.3K	0.02%	100
2022 Q1	$204K	Sell	3,939 -2,863	-42%	-$149K	0.03%	98
2021 Q4	$402K	Buy	6,802 +960	+16%	+$47.6K	0.06%	104
2021 Q3	$251K	Sell	5,842 -4,949	-46%	-$219K	0.04%	91
2021 Q2	$423K	Buy	10,791 +2,272	+27%	+$88.4K	0.06%	98
2021 Q1	$309K	Sell	8,519 -12,743	-60%	-$452K	0.05%	95
2020 Q4	$783K	Buy	21,262 +5,580	+36%	+$205K	0.32%	66
2020 Q3	$546K	Sell	15,682 -6,500	-29%	-$228K	0.28%	85
2020 Q2	$688K	Buy	+22,182	New	+$754K	0.37%	61
2019 Q4	–	Sell	-37,495	Closed	-$1.28M	–	131
2019 Q3	$1.28M	Buy	+37,495	New	+$1.36M	0.61%	44

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Rock Creek Group's PFE Position: Q4 2023 in Review

Rock Creek Group sold out of Pfizer (PFE) in Q4 2023, closing a stake of 2,776 shares — an estimated $92.1K sold.

Rock Creek Group first reported a position in PFE in Q3 2019 and held it in 15 quarters. The position peaked at $1.28M in Q3 2019. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Rock Creek Group reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Rock Creek Group sold 2,776 Pfizer shares in Q4 2023, an estimated $92.1K.
Rock Creek Group first reported a position in Pfizer in Q3 2019 and held it in 15 quarters.
Rock Creek Group's Pfizer position peaked at $1.28M in Q3 2019.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Rock Creek Group's 13F filing for Q4 2023, filed 13 Feb 2024.